AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BEVACIZUMAB
57 registrations across 13 African markets— 47 active
Markets with BEVACIZUMAB
🇿🇦South Africa
10 registrations
8 active
🇹🇿Tanzania
9 registrations
9 active
🇺🇬Uganda
6 registrations
6 active
🇨🇮Côte d'Ivoire
5 registrations
1 active
🇰🇪Kenya
5 registrations
5 active
🇿🇼Zimbabwe
4 registrations
4 active
🇹🇳Tunisia
4 registrations
0 active
🇸🇳Senegal
3 registrations
3 active
🇷🇼Rwanda
3 registrations
3 active
🇬🇭Ghana
2 registrations
2 active
🇳🇬Nigeria
2 registrations
2 active
🇲🇬Madagascar
2 registrations
2 active
🇲🇦Morocco
2 registrations
2 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AVASTIN 400MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (BEVACIZUMAB) | 🇬🇭Ghana | — | active | May 2031 |
| AVASTIN 100MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION (BEVACIZUMAB) | 🇬🇭Ghana | — | active | May 2031 |
| AVASTIN 400MG Concentrate For Solution For Infusion | 🇰🇪Kenya | F. HOFFMAN-LA ROCHE LTD | active | Apr 2031 |
| AVASTIN 100MG Concentrate For Solution For Infusion | 🇰🇪Kenya | F. HOFFMAN-LA ROCHE LTD | active | Apr 2031 |
| BEVAMAB 100 Infusion | 🇰🇪Kenya | INTAS PHARMACEUTICALS LIMITED | active | Mar 2031 |
| PERSIVIA Concentrate For Solution For Infusion | 🇰🇪Kenya | DR. REDDY’S LABORATORIES LIMITED | active | Mar 2030 |
| BEVACIZUMAB 100 EQUITY | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Feb 2030 |
| BEVACIZUMAB 400 EQUITY | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Feb 2030 |
| BEVACIZUMAB 100 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2029 |
| BEVACIZUMAB 400 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2029 |
| AVASTIN CONCENTRATE FOR SOLUTION FOR INFUSION | 🇷🇼Rwanda | Roche Diagnostics GmbH and F. Hoffmann-La Roche Ltd | active | Sept 2029 |
| RIQVIVA 400 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Nov 2028 |
| RIQVIVA 100 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Nov 2028 |
| AVASTIN ® 100 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Dec 2027 |
| ABEVMY - 400 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | BIOSIMILARS NEWCO LIMITED | active | Dec 2027 |
| ABEVMY - 100 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | BIOSIMILARS NEWCO LIMITED | active | Dec 2027 |
| AVASTIN ® 400 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Dec 2027 |
| AVASTIN 100MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Dec 2027 |
| BEVAAS 400 CONCETRATE FOR SOLUTION FOR INJECTION | 🇷🇼Rwanda | HETERO BIOPHARMA LIMITED | active | Jul 2027 |
| BEVAAS 100 CONCETRATE FOR SOLUTION FOR INJECTION | 🇷🇼Rwanda | HETERO BIOPHARMA LIMITED | active | Jul 2027 |
| BEVAMAB 400 Injection | 🇰🇪Kenya | INTAS PHARMACEUTICALS LTD | active | Apr 2027 |
| MVASI 400 mg/16 ml | 🇿🇦South Africa | Amgen South Africa (Pty)Ltd | suspended | Mar 2025 |
| MVASI 100 mg/4 ml | 🇿🇦South Africa | Amgen South Africa (Pty)Ltd | suspended | Mar 2025 |
| BEVAAS 100MG/4ML SOLUTION A DILUER POUR PERFUSION BOITE DE 4ML | 🇨🇮Côte d'Ivoire | HETERO LABS LIMITED | expired | Feb 2024 |
| BEVAAS 400MG/16ML SOLUTION A DILUER POUR PERFUSION BOITE DE 16ML | 🇨🇮Côte d'Ivoire | HETERO LABS LIMITED | expired | Feb 2024 |
| YPEVA 100MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | 🇨🇮Côte d'Ivoire | SOTHEMA | expired | Jan 2023 |
| YPEVA 400MG/16ML SOLUTION A DILUER POUR PERFUSION FLACON DE 16ML | 🇨🇮Côte d'Ivoire | SOTHEMA | expired | Jan 2023 |
| ABEVMY Solution à diluer pour perfusion / 400 mg(25mg/ml) | 🇹🇳Tunisia | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | Sept 2021 |
| ABEVMY Solution à diluer pour perfusion / 100 mg(25mg/ml) | 🇹🇳Tunisia | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | Sept 2021 |
| AVASTIN Solution injectable pour perfusion / 400 mg | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Sept 2010 |
| AVASTIN Solution injectable pour perfusion / 100 mg | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Sept 2010 |
| AVASTIN 100 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| AVASTIN 400 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| Avastin 100 mg Concentrate for solution for infusion | 🇳🇬Nigeria | — | active | — |
| Avastin 400 mg/16 mL Concentrate for solution for infusion | 🇳🇬Nigeria | — | active | — |
| Abevmy™ 400 Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | Biosimilars Newco Limited (BNCL) | active | — |
| AVASTIN SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| BEVAAS 100 Solution for injection | 🇹🇿Tanzania | HETERO BIOPHARMA LIMITED | active | — |
| BEVACIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | HETERO BIOPHARMA LIMITED, | active | — |
| ABEVMY injectable / 400 mg | 🇸🇳Senegal | MYLAN | active | — |
| BEVACIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | F. HOFFMANN LA- ROCHE | active | — |
| BEVAMAB 400 Intravenous Infusion | 🇹🇿Tanzania | Intas Pharmaceuticals Ltd | active | — |
| Abevmy™ 100 Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | Biosimilars Newco Limited (BNCL) | active | — |
| BEVACIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | HETERO BIOPHARMA LIMITED, | active | — |
| AVASTIN SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Avastin Injection | 🇹🇿Tanzania | F.Hoffmann-La Roche Limited | active | — |
| YPEVA solution pour perfusion / 25 mg/ml | 🇸🇳Senegal | SOTHEMA | active | — |
| BEVACIZUMAB PARENTERAL
ORDINARY
INFUSION DRY
VIALS/BOTTLES | 🇺🇬Uganda | JSC BIOCAD, SAINT PETERSBURG | active | — |
| AVASTIN ® 100MG/4ML SOLADP BTE (1 FL/4ML) ROCHE PRODUCTS solution à diluer pour | 🇲🇬Madagascar | ROCHE PRODUCTS | active | — |
| BEVACIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | F. HOFFMANN LA- ROCHE | active | — |
Showing 50 of 57 registrations. Sign up free to search and export all.
BEVACIZUMAB in Africa — Regulatory Overview
BEVACIZUMAB is registered across 13 African markets with 57 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Uganda, Côte d'Ivoire and 9 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 57 registrations, 47 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.